Zika virus (ZIKV), an emerging single-stranded RNA mosquito born flavivirus that has been recognized in sporadic outbreaks in Africa since its first isolation from rhesus monkeys in the Zika forest (the virus carries the name) near Uganda in 1947. The first infection in humans was documented in Tanzania and Uganda in 1952. Further outbreaks have been reported in Africa, Americas, Asia, and Pacific islands. In 2015, ZIKV wide epidemic in susceptible Brazilian population have clearly demonstrated the effectiveness of its mosquito vector, *Aedes* genus, especially *Aedes aegypti* [@bib1], [@bib2].

The recent substation increase in the number of fetal cases, neonatal birth defects, and other neurological complications reported from Brazil have prompted the World Health Organization (WHO) to declare the Zika virus "A public health emergency of international concern" on February 1, 2016 [@bib3].

The clinical manifestations of ZIKV during pregnancy are similar to those in nonpregnant women. Experimental laboratory-based and clinical studies have established a clear causal relation between maternal ZIKV infection and fetal defects [@bib4].

The virus has a high efficiency to infect human neuronal progenitor cells and affect their development. ZIKV has the ability to cross the placenta, as demonstrated by the detection of the virus genome in the amniotic fluid infants who have confirmed microcephaly as well in fetal brain tissue in microcephalic fetus of an infected pregnant woman [@bib4].

Although ZIKV has been linked to neonatal microcephaly, other abnormalities detected in prenatal sonography among ZIKV congenitally infected infant also included cerebral calcifications; fetal growth restriction and ocular abnormalities, which included bilateral macular and perimacular lesions as well as optic nerve abnormalities in most cases [@bib5], [@bib6], [@bib7], [@bib8], [@bib9].

Prevalence and clinical spectrum of congenital ZIKV disease in newborns infected prenatally are unknown. Management of infants who have congenital ZIKV disease is primarily supportive, and there is neither available vaccine nor prophylactic medications [@bib10]. However, the race is on to produce ZIKV vaccines. There are currently around 25 vaccine companies and organization groups are expediting vaccine research against ZIKV [@bib11].

Healthcare providers should advice pregnant women to postpone their travel to endemic areas. If they have to travel, they should strictly follow steps to avoid mosquito bites [@bib12]. Pediatricians should work closely with obstetricians to identify infant with maternal risk or diagnosed with ZIKV infection, and they have to standardize their approaches to diagnostic evaluation for congenital Zika virus infection [@bib10], [@bib12], [@bib13].

The list pathogens related to intrauterine infections continues to grow with the identification of ZIKV. The pattern of neurological abnormalities seen with congenital ZIKV infection is similar to what is seen with cytomegalovirus.

The acronym for the common congenital infections that changed from TORCH to STORCH and CHEAPTORCHES need to be further expanding to ZiCHEAPTORCHES ([Table 1](#tbl1){ref-type="table"}) in order to include another important congenital infection, the Zika virus [@bib14], [@bib15], [@bib16].Table 1Congenital infection acronym: ZiCHEAPTORCHESTable 1AcronymPathogens**ZiZi**ka virus**CC**hickenpox and shingles**HH**epatitis C, D, E**EE**nteroviruses**AA**IDS (HIV infection)**PP**arvovirus B19**TT**oxoplasmosis**OO**ther (Group B streptococcus, Listeria, Streptococcus, Candida, Lyme disease)**RR**ubella**CC**ytomegalovirus**HH**erpes simplex**EE**verything else sexually transmitted (Gonorrhea, *Chlamydia* infection, Ureaplasma urealyticum, human papillomavirus**SS**yphilis
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